BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas-Reference-Cited by-同舟云学术

BAP1 Is Altered by Copy Number Loss, Mutation, and/or Loss of Protein Expression in More Than 70% of Malignant Peritoneal Mesotheliomas

Published:2017-04 Issue:4 Volume:12 Page:724-733
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Leblay Noémie,Leprêtre Frédéric,Le Stang Nolwenn,Gautier-Stein Amandine,Villeneuve Laurent,Isaac Sylvie,Maillet Denis,Galateau-Sallé Françoise,Villenet Céline,Sebda Shéhérazade,Goracci Alexandra,Byrnes Graham,McKay James D,Figeac Martin,Glehen Olivier,Gilly François-Noël,Foll Matthieu,Fernandez-Cuesta Lynnette,Brevet Marie

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference37 articles.

1. BAP1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization;Ventii;Cancer Res,2008

2. An emerging model for BAP1's role in regulating cell cycle progression;Eletr;Cell Biochem Biophys,2011

3. BAP1 is Phosphorylated at serine 592 in S-phase following DNA damage;Eletr;FEBS Lett,2013

4. Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair;Yu;Proc Natl Acad Sci U S A,2014

5. BAP1 and Cancer;Carbone;Nat Rev Cancer,2013

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Female Adnexal Tumor of Probable Wolffian Origin (Wolffian Tumor);American Journal of Surgical Pathology;2024-06-25

2. Immunohistochemical detection of cancer genetic abnormalities;Pathology - Research and Practice;2024-03

3. Organoids derived from patients provide a new opportunity for research and individualized treatment of malignant peritoneal mesothelioma;Molecular Cancer;2024-01-10

4. Combined Inhibition of EZH2 and FGFR is Synergistic in BAP1-deficient Malignant Mesothelioma;Cancer Research Communications;2024-01-03

5. Mesothelioma: Peritoneal, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology;Journal of the National Comprehensive Cancer Network;2023-09